Skip to main content

Table 1 Subjects characteristics

From: Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals

Amyloid+ (n = 183)

CN (n = 93)

MCI (n = 60)

Dementia (n = 30)

p value

Age in years

75.67 (7.25)

76.16 (6.82)

76.95 (7.90)

0.692

Sex (male/female)

40/53

35/25

14/16

0.175

Years of education

16.59 (2.30)

15.78 (2.73)

16.1 (2.34)

0.132

MMSE score

28.83 (1.48)b,c

27.2 (2.32)a,c

22.27 (3.85)a,b

 < 0.001

ADAS13 score

12.88 (5.27)b,c

19.44 (6.92)a,c

32.50 (9.32)a,b

 < 0.001

ADNI-MEM score

0.95 (0.56)b,c

0.13 (0.60)a,c

 − 0.73 (0.73)a,b

 < 0.001

Amyloid-PET CL

62.10 (32.54)c

75.72 (37.44)

88.30 (36.61)a

 < 0.001

Global Tau-PET SUVR

1.13 (0.09)b,c

1.22 (0.18)a,c

1.38 (0.36)a,b

 < 0.001

Braak0/BraakI+/BraakI–IV+/BraakI–VI+/Braakatypical+

68/16/6/1/2

22/14/13/8/3

6/4/6/13/1

 < 0.001

Mean cognitive follow-up in years

2.03 (0.68)

1.88 (0.87)

1.67 (0.73)

0.072

Amyloid (n = 213)

CN (n = 146)

MCI (n = 62)

Dementia (n = 5)

p value

Age in years

72.76 (6.87) b

75.47 (8.60) a

71.22 (7.45)

0.045

Sex (female/male)

60/86

39/23

3/2

0.014

Years of education

16.95 (2.42)c

16.18 (3.00)

14 (2.83)a

0.011

MMSE score

29.21 (0.98)b,c

28.56 (1.72)a,c

24.4 (1.14)a,b

 < 0.001

ADAS13 score

11.16 (4.29)b,c

16.19 (5.43)a,c

30.07 (4.39)a,b

 < 0.001

ADNI-MEM score

1.10 (0.60)b,c

0.60 (0.56)a,c

 − 0.61 (0.59)a,b

 < 0.001

Amyloid-PET CL

5.60 (8.82)b

 − 0.72 (12.34)a

 − 3.03 (8.87)

 < 0.001

Global Tau-PET SUVR

1.09 (0.07)

1.08 (0.08)

1.08 (0.07)

0.811

Braak0/BraakI+/BraakI–IV+/BraakI–VI+/Braakatypical+

137/5/1/2/1

56/4/1/0/1

4/1/0/0/0

0.718

Mean cognitive follow-up in years

2.18 (0.62)

2.01 (0.92)

1.53 (0.58)

0.056

  1. Values are presented as mean (SD)
  2. p values were derived from ANOVAs for continuous measures and from chi-squared tests for categorical measures
  3. MMSE Mini-Mental State Examination, ADAS13 Alzheimer’s disease assessment scale, cognitive subscale, ADNI-MEM episodic memory composite score
  4. Mean values significantly (p < 0.05, post hoc tests) different from aCN, bMCI, and cDementia